Co-Authors
This is a "connection" page, showing publications co-authored by MICHAEL ELLIOT KUPFERMAN and DIANA BELL.
Connection Strength
1.420
-
Comparative transcriptome analysis of sinonasal inverted papilloma and associated squamous cell carcinoma: Out-HOXing developmental genes. Head Neck. 2019 09; 41(9):3090-3104.
Score: 0.177
-
Human epidermal growth factor receptor 2/neu as a novel therapeutic target in sinonasal undifferentiated carcinoma. Head Neck. 2016 04; 38 Suppl 1:E1926-34.
Score: 0.141
-
Prognostic factors in adenocarcinoma of the salivary glands. Oral Oncol. 2015 Jun; 51(6):610-5.
Score: 0.134
-
Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes. Head Neck Pathol. 2015 Mar; 9(1):51-9.
Score: 0.125
-
Prognostic factors associated with decreased survival in patients with acinic cell carcinoma. JAMA Otolaryngol Head Neck Surg. 2013 Nov; 139(11):1195-202.
Score: 0.121
-
Primary colonic-type adenocarcinoma of the base of the tongue: a previously unreported phenotype. Hum Pathol. 2009 Dec; 40(12):1798-802.
Score: 0.090
-
Correction: Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic Targets. Clin Cancer Res. 2023 Jul 14; 29(14):2737.
Score: 0.059
-
Phase II Clinical Trial of Axitinib and Avelumab in Patients With Recurrent/Metastatic Adenoid Cystic Carcinoma. J Clin Oncol. 2023 05 20; 41(15):2843-2851.
Score: 0.058
-
Soft Tissue Sarcomas of the Head and Neck Region with Skull Base/Intracranial Invasion: Review of Surgical Outcomes and Multimodal Treatment Strategies: A Retrospective Case Series. Curr Oncol. 2022 09 14; 29(9):6540-6550.
Score: 0.056
-
Long-Term Outcomes of Olfactory Neuroblastoma: MD Anderson Cancer Center Experience and Review of the Literature. Laryngoscope. 2022 02; 132(2):290-297.
Score: 0.052
-
Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic Targets. Clin Cancer Res. 2021 02 01; 27(3):852-864.
Score: 0.049
-
Clinical Implication of Diagnostic and Histopathologic Discrepancies in Sinonasal Malignancies. Laryngoscope. 2021 05; 131(5):E1468-E1475.
Score: 0.049
-
Surgical management of carcinomas of the infratemporal fossa and skull base: patterns of failure and predictors of long-term outcomes. J Neurosurg. 2020 Jun 12; 134(5):1392-1398.
Score: 0.048
-
Induction Chemotherapy Response as a Guide for Treatment Optimization in Sinonasal Undifferentiated Carcinoma. J Clin Oncol. 2019 02 20; 37(6):504-512.
Score: 0.043
-
Prognostic factors and survival in adenoid cystic carcinoma of the sinonasal cavity. Head Neck. 2018 12; 40(12):2596-2605.
Score: 0.043
-
Early Stage olfactory neuroblastoma and the impact of resecting dura and olfactory bulb. Laryngoscope. 2018 06; 128(6):1274-1280.
Score: 0.040
-
Transoral endoscopic head and neck surgery (eHNS) for minor salivary gland tumors of the oropharynx. Cancers Head Neck. 2017; 2:5.
Score: 0.039
-
Outcomes for olfactory neuroblastoma treated with induction chemotherapy. Head Neck. 2017 08; 39(8):1671-1679.
Score: 0.039
-
Esthesioneuroblastoma. Neurosurg Clin N Am. 2013 Jan; 24(1):51-65.
Score: 0.029
-
Establishment and characterization of novel cell lines from sinonasal undifferentiated carcinoma. Clin Cancer Res. 2012 Nov 15; 18(22):6178-87.
Score: 0.028